NL-OMON37506
Withdrawn
Phase 4
Renal Sympathetic Denervation after Renal Transplantation Study - I - RESTART - I
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 10
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hypertension despite 2 or more anti\-hypertensive drugs
- •Functioning transplant kidney in situ
Exclusion Criteria
- •Renal artery stenosis of native of transplant reanl arteries
- •Primary hyperaldosteronisme
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Phase 4
Renal Sympathetic Denervation in patients with therapy-resistant Catecholamine Polymorphic Ventricular Tachycardia (CPVT) and Long QT Syndrome (LQTS) * RESIDENT StudyNL-OMON41010Academisch Medisch Centrum20
Completed
Not Applicable
Effect of renal sympathetic denervation on renal and overall sympathetic output in patients with therapy resistant hypertensioTherapy resistant hypertensionrenal sympathetic denervation1001842410057166NL-OMON37991Academisch Medisch Centrum30
Completed
Not Applicable
Effect of renal denervation on Muscle Sympathetic Nerve Activity in patients with uncontrolled hypertensioNL-OMON41590niversitair Medisch Centrum Utrecht20
Completed
Phase 3
SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension.hypertensiehigh blood pressurehypertension10038430NL-OMON39831niversitair Medisch Centrum Utrecht570
Withdrawn
Not Applicable
SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension: from rescue to resolve.hoge bloeddrukhypertension high blood pressure10038430NL-OMON37568niversitair Medisch Centrum Utrecht260